Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
Selective inhibitor studies in macrophages implicate class II HDAC enzymes in TLR-
mediated inflammatory pathways and class I HDACs as negative regulators. Broad …
mediated inflammatory pathways and class I HDACs as negative regulators. Broad …
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
MA Halili, MR Andrews, LI Labzin… - Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS.
MA Halili, MR Andrews, LI Labzin… - Journal of Leukocyte …, 2010 - europepmc.org
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
MA Halili, MR Andrews, LI Labzin… - Journal of Leukocyte …, 2010 - research.ed.ac.uk
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
MA Halili, MR Andrews, LI Labzin… - Journal of …, 2010 - research.monash.edu
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll‐like receptor 4 agonist LPS
MA Halili, MR Andrews, LI Labzin… - Journal of Leukocyte …, 2010 - Wiley Online Library
Broad‐spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
[引用][C] Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
MA Halili, MR Andrews, LI Labzin… - Journal of …, 2010 - espace.library.uq.edu.au
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti …
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
MA Halili, MR Andrews, LI Labzin, K Schroder… - Journal of Leukocyte …, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Selective inhibitor studies in macrophages
implicate class II HDAC enzymes in TLR-mediated inflammatory pathways and class I …
implicate class II HDAC enzymes in TLR-mediated inflammatory pathways and class I …